Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progabide for previously untreated absence epilepsy.

H Stefan1, P Plouin, H Fichsel

  • 1Universitäts-Nervenklinik und Poliklinik/Epileptologie, University of Bonn, F.R.G.

Epilepsy Research
|March 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimal-invasive, ablative surgery - Potential and limitations for a curative treatment approach in epilepsy.

Epilepsy research·2018
Same author

Epileptogenicity and pathology - Under consideration of ablative approaches.

Epilepsy research·2018
Same author

Drug-induced hypersensitivity syndrome caused by valproic acid as a monotherapy for epilepsy: First case report in Asian population.

Epilepsy & behavior case reports·2017
Same author

Automatic multimodal detection for long-term seizure documentation in epilepsy.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2017
Same author

Single-dose intravenous administration of antiepileptic drugs induces rapid and reversible remodeling in the brain: Evidence from a voxel-based morphometry evaluation of valproate and levetiracetam in rhesus monkeys.

Neuroscience·2015
Same author

Epilepsy in the elderly: restrictions, fears, and quality of life.

Acta neurologica Scandinavica·2014

Progabide monotherapy showed limited efficacy in reducing generalized spike-wave paroxysms in absence epilepsy patients. While some initial anti-absence activity was observed, tolerance developed, and seizure frequency was not significantly reduced.

Area of Science:

  • Neurology
  • Clinical Pharmacology

Background:

  • Absence epilepsy is characterized by generalized spike-wave discharges on electroencephalogram (EEG).
  • Progabide is an antiepileptic drug investigated for its efficacy in various seizure types.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of progabide monotherapy in patients with absence epilepsy.
  • To assess changes in EEG paroxysmal activity and seizure frequency during progabide treatment.

Main Methods:

  • Ten patients with absence epilepsy and generalized spike-wave paroxysms were enrolled.
  • Patients received progabide as monotherapy.
  • Clinical data and serial 24-hour long-term EEG recordings were compared pre-treatment and during treatment.

Main Results:

Related Experiment Videos

  • The average total spike-wave duration in 24 hours slightly decreased from 810 sec to 699 sec, with a reversal in 4 cases at follow-up.
  • A marked anticonvulsant effect was not confirmed; initial anti-absence activity appeared subject to tolerance development.
  • Side effects were rarely observed and not severe.

Conclusions:

  • Progabide monotherapy demonstrated limited efficacy in reducing EEG paroxysmal activity and seizure frequency in absence epilepsy.
  • The development of tolerance may limit the long-term effectiveness of progabide.
  • Progabide was generally well-tolerated in this patient cohort.